A new economic study reveals that transitioning German smokers to less harmful alternatives like vaping could drastically reduce disease burdens and save the national healthcare system up to €75 billion between 2026 and 2040.
- Massive Cost Savings: A realistic adoption scenario projects €48 billion in direct medical savings, while an optimistic model reaches €75 billion.
- Combustion is the Culprit: Researchers emphasize that burning tobacco, not nicotine, drives health damage, with vapes reducing toxic exposure by 60% to 95%.
- Risk-Proportionate Policy: Experts advocate for regulations that differentiate between combustible cigarettes and non-combustible alternatives while maintaining strict youth protection.
Independent researchers from the Institute for Growth Opportunities and Innovation (IWCI) and IU International University have concluded that embracing Tobacco Harm Reduction (THR) could save Germany up to €75 billion. Amidst stagnant national smoking rates, the newly released study confirms that shifting adult smokers to non-combustible alternatives directly lowers disease burdens and slashes direct medical expenses.
Commissioned by HG Innovation Limited, the health-economic microsimulation analyzed the potential financial impact of smokers switching to vapes between 2026 and 2040. The model focused exclusively on direct healthcare costs, including hospital stays, medical treatments, and long-term nursing care.
Depending on the adoption rate of risk-reduced products, the study outlines three distinct economic outcomes for the German healthcare system:
| Adoption Scenario | Projected Healthcare Savings (2026-2040) |
|---|---|
| Conservative | €15 Billion |
| Realistic | €48 Billion |
| Optimistic | €75 Billion |
StagBar Vape 4in1 80K Puffs Disposable
The Stagbar 4-in-1 80,000 is a revolutionary high-capacity disposable featuring 4 flavors and 4 independent mesh coils in one device, delivering an industry-leading 80,000 puffs.
Even a modest shift in consumer behavior yields substantial public health benefits. Prof. Dr. Florian Hummel of IU International University noted that if just 10% of smokers transition to vaping annually over a three-year period, tobacco-related illnesses would drop by 8% to 10%. This moderate behavioral change alone would generate up to €3 billion in annual healthcare savings.
The study strongly reiterates a core scientific consensus: the combustion of tobacco, rather than nicotine itself, is the primary driver of smoking-related diseases. Dr. Dominic Multerer, the study’s director at IWCI, highlighted that international biomarker data shows a 60% to 95% reduction in key pollutants when smokers switch to e-cigarettes.
Prof. Dr. Bernhard-Michael Mayer, a pharmacologist formerly at the University of Graz, supported this distinction. “The central message is: vape instead of smoke,” he stated. “The greatest health risks arise from combustion products—many of these risks are eliminated when vaping.”
While complete nicotine abstinence remains the primary goal of public health prevention, researchers argue that harm reduction is a vital complementary strategy. Millions of adults in Germany continue to smoke despite decades of traditional tobacco control measures, necessitating pragmatic alternatives for those unable or unwilling to quit abruptly.
Consequently, the study advocates for a risk-proportionate regulatory framework. Authors warn that overly restrictive policies on non-combustible products could trigger unintended behavioral shifts back to smoking. Instead, they recommend clear differentiation between product categories, mandatory quality standards, and controlled market mechanisms.
Crucially, the researchers emphasize that effective youth protection and Tobacco Harm Reduction are not mutually exclusive. Citing international examples like the UK, Sweden, and Japan, the report demonstrates that strictly regulated markets can successfully drive down smoking rates while safeguarding minors.
